Experienced in Alpha-1 Antitrypsin Deficiency (AATD)

Dr. Boris I. Medarov

Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine
Albany Medical College
47 New Scotland Ave, 
Albany, NY 
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Albany Medical College
47 New Scotland Ave, 
Albany, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Boris Medarov is a Pulmonary Medicine specialist and a Sleep Medicine provider in Albany, New York. Dr. Medarov is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Pulmonary Hypertension, Asthma, Pulmonary Veno-Occlusive Disease, Gastrostomy, and Ureteroscopy.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Sleep Medicine
Intensive Care Medicine
Licenses
Critical Care Medicine in CT
Hospital Affiliations
Albany Medical Center Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

ALBANY MEDICAL COLLEGE
47 New Scotland Ave, Albany, NY 12208
Other Locations
ALBANY MEDICAL COLLEGE
16 New Scotland Ave, Fl 2, Albany, NY 12208

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Enrollment Status: Terminated
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

17 Total Publications

An Analysis of Adverse Events Associated with Mandibular Repositioning Appliances (MRA)- Study of the FDA Manufacturer and User Facility Device Experience (MAUDE) Database.
An Analysis of Adverse Events Associated with Mandibular Repositioning Appliances (MRA)- Study of the FDA Manufacturer and User Facility Device Experience (MAUDE) Database.
Journal: Respiratory medicine
Published: April 13, 2025
Similar Doctors
Distinguished in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. David M. Serlin
Pulmonary Medicine | Intensive Care Medicine | Allergy and Immunology
Distinguished in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. David M. Serlin
Pulmonary Medicine | Intensive Care Medicine | Allergy and Immunology

Mass General Brigham Medical Group Western Massachusetts Inc

30 Locust St, 
Northampton, MA 
 (61.3 miles away)
413-582-2441
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Serlin is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Northampton, Massachusetts. Dr. Serlin is rated as a Distinguished provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Bronchiectasis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Endoscopy.

Advanced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Charles A. Dumont
Pulmonary Medicine | Intensive Care Medicine
Advanced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Charles A. Dumont
Pulmonary Medicine | Intensive Care Medicine

Mass General Brigham Medical Group Western Massachusetts Inc

30 Locust St, 
Northampton, MA 
 (61.3 miles away)
413-582-2441
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Charles Dumont is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Northampton, Massachusetts. Dr. Dumont is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Chronic Cough, Lung Metastases, Gastrostomy, and Endoscopy. Dr. Dumont is currently accepting new patients.

Advanced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Abul K. Azad
Pulmonary Medicine | Hospital Medicine | Emergency Medicine
Advanced in Alpha-1 Antitrypsin Deficiency (AATD)
Dr. Abul K. Azad
Pulmonary Medicine | Hospital Medicine | Emergency Medicine

Capital Pulmonary-Intensivist Physician, P.C.

319 S Manning Blvd, Suite 116, 
Albany, NY 
 (1.5 miles away)
518-459-1800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Abul Azad is a Pulmonary Medicine specialist and a Hospital Medicine provider in Albany, New York. Dr. Azad is rated as a Distinguished provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Asthma, Asthma in Children, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Tissue Biopsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Medarov's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile